Post by
Righttothetop on Oct 15, 2020 9:26am
Next Steps
Given that LABS has so far exceeded in executing on their plans for the future and that they actually pulled off a large pharma partnership (as I really did hope they would), here is what I see for the near future:
1) Secure a Stada-like deal for NA. With obvious access to Bains, that might be easier now than one would think but a NA deal (primarily for the US) with a Tier 1 or 2 pharma would be wonderful
2) Get into the beverage market with a partnership with RedBull or Monster. You have to believe that those 'X-Games' type companies are licking their chops to find a way to engage their market with a CBD/THC based offering and LABS, with the credibilty it now has globally and their GMP manufacturing platform, offers an excellent partner with plenty of scale and regionalized production. Realize that this is a bit of a stretch and outside of the pharma business model, but this would be massive. May as well scoop the others before they get there....cause they will, especially if the US opens up.
3) Keep working with research entities and get the brand out there.
4) Get the damn SP up so we can list in the US. We have all this high horsepower on the Board, we need to use them! And when I mean get the SP up, I don't mean a reverse split.
In the end, LABS is doing exactly what they said they would, and have been executing flawlessly. They need to secure EU GMP quickly, to maintain the positive street cred and start moving to operational excellence to give the markets some peace.
While the price is bouncing around for a while, and while COVID didn't do us any favours, this company is an investment that will pay off large, sooner than one thinks.
IMO
Comment by
allibabba on Oct 15, 2020 9:47am
I agree with everything you mention aside from the US. If the US legalizes every canadian company will disappear. Do you really think they will canadian companies take profits from US companies. Not a hope in hell.
Comment by
Righttothetop on Oct 15, 2020 9:52am
If the Canadian company is listed in the US and has ties to the US, the US would allow it...hence the reason to get into bed with a US based pharma, list on a US exchange.
Comment by
allibabba on Oct 15, 2020 9:58am
That's a great point but keep in mind there are companies in the US already doing what LABS does. The cannabis medical industry was alive and well long before LABS existed. I am invested here and hope for the best but I do like to look at both sides of the coin. I am also a bit bitter at the recent plunge but I should have known better.
Comment by
allibabba on Oct 15, 2020 4:44pm
All good points but what I'd like to know is who has been supplying the cannabis medical companies before Medipharm came along. Oils and capsules have been available since at least 2009 so someone already has this in place. I don't know who it is but I'm willing to bet there are already large pharmaceutical companies doing exactly this.
Comment by
lscfa on Oct 16, 2020 1:16am
LP's like Tilray have had their own extraction ops for years. Some newcomers outsource extraction. MediPharm and Valens are going beyond extraction and becoming contract manufacturers.
Comment by
Lemoyne on Oct 16, 2020 9:18am
https://equity.guru/2020/10/15/medipharm-labs-labs-t-hitches-their-white-label-distribution-wagon-to-european-pharma-giant-stada-arzneimittel-ag-stadf-q/
Comment by
BushweedJA on Oct 18, 2020 9:24pm
This post has been removed in accordance with Community Policy
Comment by
JFKFKJGKF on Oct 18, 2020 10:32pm
This post has been removed in accordance with Community Policy
Comment by
allibabba on Oct 15, 2020 4:46pm
If someone can prove to me that there are not large companies who already have a foothold on this i will certainly buy more shares. For now I am hopeful but skeptical.
Comment by
Lemoyne on Oct 15, 2020 8:11pm
Although not US based, Teva is in it for sure, big pharma.
Comment by
BushweedJA on Oct 16, 2020 1:05am
This post has been removed in accordance with Community Policy